{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:22:29Z","timestamp":1771636949216,"version":"3.50.1"},"reference-count":74,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Psoriatic patients present various infectious risk factors, but there are few studies in the literature evaluating the actual impact of psoriasis in severe staphylococcal skin infections. Our narrative review of the literature suggests that psoriatic patients are at increased risk of both colonization and severe infection, during hospitalization, by S. aureus. The latter also appears to play a role in the pathogenesis of psoriasis through the production of exotoxins. Hospitalized psoriatic patients are also at increased risk of MRSA skin infections. For this reason, new molecules are needed that could both overcome bacterial resistance and inhibit exotoxin production. In our opinion, in the near future, topical quorum sensing inhibitors in combination with current anti-MRSA therapies will be able to overcome the increasing resistance and block exotoxin production. Supplementation with Vitamin E (VE) or derivatives could also enhance the effect of anti-MRSA antibiotics, considering that psoriatic patients with metabolic comorbidities show a low intake of VE and low serum levels, making VE supplementation an interesting new perspective.<\/jats:p>","DOI":"10.3390\/antibiotics11111504","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T23:45:00Z","timestamp":1667087100000},"page":"1504","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-4067","authenticated-orcid":false,"given":"Giulio","family":"Rizzetto","sequence":"first","affiliation":[{"name":"Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Molinelli","sequence":"additional","affiliation":[{"name":"Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-1026","authenticated-orcid":false,"given":"Giulia","family":"Radi","sequence":"additional","affiliation":[{"name":"Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Cirioni","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Brescini","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giacometti","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[{"name":"Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriana","family":"Simonetti","sequence":"additional","affiliation":[{"name":"Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jdermsci.2008.12.012","article-title":"VEGF, survivin and NOS overexpression in psoriatic skin: Critical role of nitric oxide synthases","volume":"54","author":"Simonetti","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13052-017-0330-7","article-title":"Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: A multicentre survey","volume":"43","author":"Gesualdo","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/jdv.14114","article-title":"Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis","volume":"31","author":"Gisondi","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2006.12.005","article-title":"The pathogenic role of tissue-resident immune cells in psoriasis","volume":"28","author":"Boyman","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaad.2005.10.057","article-title":"Innate and adaptive immunity and the pathophysiology of psoriasis","volume":"54","author":"Gaspari","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2005.06645.x","article-title":"Psoriasis: Dysregulation of innate immunity","volume":"152","author":"Bos","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Marani, A., Rizzetto, G., Radi, G., Molinelli, E., Capodaglio, I., Offidani, A., and Simonetti, O. (2022). Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review. Healthcare, 10.","DOI":"10.3390\/healthcare10071190"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000247421","article-title":"Plasma Lipid Changes in Psoriatic Children","volume":"185","author":"Simonetti","year":"1992","journal-title":"Dermatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2016.04.005","article-title":"Serious infections in hospitalized patients with psoriasis in the United States","volume":"75","author":"Hsu","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jhin.2016.06.011","article-title":"Staphylococcus aureus and surgical site infections: Benefits of screening and decolonization before surgery","volume":"94","author":"Humphreys","year":"2016","journal-title":"J. Hosp. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1524-475X.2007.00321.x","article-title":"Biofilms in chronic wounds","volume":"16","author":"James","year":"2008","journal-title":"Wound Repair Regen."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","article-title":"The prevalence of biofilms in chronic wounds: A systematic review and meta-analysis of published data","volume":"26","author":"Malone","year":"2017","journal-title":"J. Wound Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00020-18","DOI":"10.1128\/CMR.00020-18","article-title":"Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology","volume":"31","author":"Lakhundi","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e199951","DOI":"10.1001\/jamanetworkopen.2019.9951","article-title":"Prevalence of Deep Surgical Site In-fection After Repair of Periarticular Knee Fractures: A Systematic Review and Meta-analysis","volume":"2","author":"Norris","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_16","first-page":"274","article-title":"Skin and soft tissue infections due to CA-MRSA","volume":"106","author":"Scheurich","year":"2009","journal-title":"Mo. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/path.4360","article-title":"Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function","volume":"233","author":"Roy","year":"2014","journal-title":"J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1684\/ejd.2009.0663","article-title":"High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis","volume":"19","author":"Balci","year":"2009","journal-title":"Eur. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2000.tb09350.x","article-title":"Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome","volume":"192","author":"Yarwood","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08923970801946808","article-title":"Streptococcus sp. and Staphylococcus aureus isolates from patients with psoriasis possess genes that code for toxins (superantigens): Clinical and therapeutic implications","volume":"30","author":"Jenbazian","year":"2008","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1468-3083.2010.03898.x","article-title":"Modulation of Interleukin-8 and staphylococcal flora by Av\u00e8ne hydrotherapy in patients suffering from chronic inflammatory dermatoses","volume":"25","author":"Casas","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40168-018-0533-1","article-title":"Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization","volume":"6","author":"Chang","year":"2018","journal-title":"Microbiome"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Takahashi, T., and Yamasaki, K. (2020). Psoriasis and Antimicrobial Peptides. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186791"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature09074","article-title":"Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization","volume":"465","author":"Iwase","year":"2010","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bjd.15366","article-title":"Risks for Staphylococcus aureus colonization in patients with psoriasis: A systematic review and meta-analysis","volume":"177","author":"Ng","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/s41467-019-12253-y","article-title":"Microbe-host interplay in atopic dermatitis and psoriasis","volume":"10","author":"Fyhrquist","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nri3010","article-title":"Immunity against Staphylococcus aureus cutaneous infections","volume":"11","author":"Miller","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2013.00507","article-title":"Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design","volume":"4","author":"Brown","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e9912","DOI":"10.5812\/jjm.9912","article-title":"The Rise of Staphylococcal Super Antigens in Psoriatic Patients, a Case-Control Study","volume":"7","author":"Atefi","year":"2014","journal-title":"Jundishapur J. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ajd.12895","article-title":"Psoriasis and infection. A clinical practice narrative","volume":"60","author":"Rademaker","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaad.2005.02.034","article-title":"Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects","volume":"53","author":"Tomi","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjd.12214","article-title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: Final results from 5 years of follow-up","volume":"168","author":"Papp","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2010.12.005","article-title":"Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL","volume":"66","author":"Gordon","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamadermatol.2021.2599","article-title":"Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis","volume":"157","author":"Penso","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Infectious Diseases Society of America Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1093\/cid\/ciz004","article-title":"Current Treatment Options for Acute Skin and Skin-structure Infections","volume":"68","author":"Golan","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"E377","DOI":"10.1111\/1469-0691.12235","article-title":"Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010\u20132011): Assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study","volume":"19","author":"Garau","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1517\/17425255.2015.1098617","article-title":"Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones","volume":"11","author":"Douros","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e20162477","DOI":"10.1542\/peds.2016-2477","article-title":"Daptomycin for Complicated Skin Infections: A Randomized Trial","volume":"139","author":"Bradley","year":"2017","journal-title":"Pediatrics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jiac.2021.11.019","article-title":"Efficacy and safety of daptomycin in Japanese pediatric participants with complicated skin and soft tissue infections or bacteremia caused by gram-positive cocci","volume":"28","author":"Iwata","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rizzetto, G., Molinelli, E., Radi, G., Diotallevi, F., Cirioni, O., Brescini, L., Giacometti, A., Offidani, A., and Simonetti, O. (2022). Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review. Antibiotics, 11.","DOI":"10.3390\/antibiotics11070944"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00606-17","DOI":"10.1128\/AAC.00606-17","article-title":"Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model","volume":"61","author":"Simonetti","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.medmal.2016.01.006","article-title":"Eosinophilic pneumonia: Daptomycin-induced lung complication","volume":"46","author":"Akcaer","year":"2016","journal-title":"Med. Mal. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10096-011-1498-1","article-title":"In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection","volume":"31","author":"Silvestri","year":"2012","journal-title":"Eur. J. Clin. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/TCRM.S271445","article-title":"Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization","volume":"17","author":"Simonetti","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e02062-19","DOI":"10.1128\/AAC.02062-19","article-title":"New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection","volume":"64","author":"Simonetti","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Jame, W., Basgut, B., and Abdi, A. (2021). Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260539"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/fmb-2021-0120","article-title":"New insight into old and new antimicrobial molecules targeting quorum sensing for MRSA wound infection","volume":"17","author":"Simonetti","year":"2022","journal-title":"Future Microbiol."},{"key":"ref_50","first-page":"269","article-title":"Focus: Infectious diseases: Vancomycin resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-020-00714-9","article-title":"The global prevalence of Daptomycin, Tigecycline, Quinupristin\/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: A systematic review and meta-analysis","volume":"9","author":"Shariati","year":"2020","journal-title":"Antimicrob Resist. Infect Control"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3201\/eid2209.160044","article-title":"Multidrug-Resistant Staphylococcus aureus, India, 2013\u20132015","volume":"22","author":"Kumar","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2174\/1568026618666181022120711","article-title":"RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of S. aureus Biofilm Infections","volume":"18","author":"Ciulla","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/microbiolspec.GPP3-0031-2018","article-title":"Regulation of Staphylococcus aureus Virulence","volume":"7","author":"Jenul","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.01340-07","article-title":"RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus","volume":"52","author":"Simonetti","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/039139881003300904","article-title":"Molecular Mechanisms of RIP, an Effective Inhibitor of Chronic Infections","volume":"33","author":"Kiran","year":"2010","journal-title":"Int. J. Artif. Organs"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Simonetti, O., Cirioni, O., Cacciatore, I., Baldassarre, L., Orlando, F., Pierpaoli, E., Lucarini, G., Orsetti, E., Provinciali, M., and Fornasari, E. (2016). Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151956"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/AAC.04767-14","article-title":"Novel Quorum-Quenching Agents Promote Methicillin-Resistant Staphylococcus aureus (MRSA) Wound Healing and Sensitize MRSA to \u03b2-Lactam Antibiotics","volume":"59","author":"Kuo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00172-20","DOI":"10.1128\/AAC.00172-20","article-title":"Novel Peptide from Commensal Staphylococcus simulans Blocks Methicillin-Resistant Staphylococcus aureus Quorum Sensing and Protects Host Skin from Damage","volume":"64","author":"Brown","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"42275","DOI":"10.1038\/srep42275","article-title":"Virulence Inhibitors from Brazilian Peppertree Block Quorum Sensing and Abate Dermonecrosis in Skin Infection Models","volume":"10","author":"Muhs","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.celrep.2019.03.018","article-title":"Apicidin Attenuates MRSA Virulence through Quorum-Sensing Inhibition and Enhanced Host Defense","volume":"27","author":"Parlet","year":"2019","journal-title":"Cell Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.peptides.2007.12.011","article-title":"Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model","volume":"29","author":"Simonetti","year":"2008","journal-title":"Peptides"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.phymed.2017.09.011","article-title":"Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound","volume":"36","author":"Pierpaoli","year":"2017","journal-title":"Phytomedicine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1099\/jmm.0.032516-0","article-title":"Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus","volume":"60","author":"Provinciali","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/dkr440","article-title":"Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation","volume":"67","author":"Simonetti","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_67","first-page":"606","article-title":"Association of serum lipid profiles and dietary intakes of vitamin E and fiber with psoriasis severity","volume":"12","author":"Yazdanpanah","year":"2021","journal-title":"Caspian J. Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Liu, X., Yang, G., Luo, M., Lan, Q., Shi, X., Deng, H., Wang, N., Xu, X., and Zhang, C. (2021). Serum vitamin E levels and chronic inflammatory skin diseases: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0261259"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e134343","DOI":"10.1172\/jci.insight.134343","article-title":"Dual-wavelength photo-killing of methicillin-resistant Staphylococcus aureus","volume":"5","author":"Leanse","year":"2020","journal-title":"JCI Insight."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/phpp.12650","article-title":"Epidermal barrier changes in patients with psoriasis: The role of phototherapy","volume":"37","author":"Ana","year":"2021","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.3390\/ijms221910841","article-title":"Skin Barrier Dysregulation in Psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Petit, R., Cano, A., Ortiz, A., Espina, M., Prat, J., Mu\u00f1oz, M., Severino, P., Souto, E., Garc\u00eda, M., and Pujol, M. (2021). Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094983"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1039\/C7NR08499D","article-title":"Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus (MRSA)","volume":"10","author":"Kadiyala","year":"2018","journal-title":"Nanoscale"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zarenezhad, E., Abdulabbas, H.T., Marzi, M., Ghazy, E., Ekrahi, M., Pezeshki, B., Ghasemian, A., and Moawad, A.A. (2022). Nickel Nanoparticles: Applications and Antimicrobial Role against Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics, 11.","DOI":"10.3390\/antibiotics11091208"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/11\/1504\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:05:17Z","timestamp":1760144717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/11\/1504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["antibiotics11111504"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11111504","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}